# Semaglutide for Low Back Pain

> **NCT07731256** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 250 (estimated)

## Conditions studied

- Lower Back Pain
- Obesity (BMI>30)
- Chronic Lower Back Pain
- glp1 Agonist

## Interventions

- **DRUG:** Semaglutide (administered by PDS290 pen-injector)
- **DRUG:** Placebo (administered by PDS290 pen-injector)

## Key facts

- **NCT ID:** NCT07731256
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-02-01
- **Primary completion:** 2031-01-01
- **Final completion:** 2031-09-01
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07731256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07731256, "Semaglutide for Low Back Pain". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07731256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*